| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.057 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |